Details for 2022185801

Up to date per 01.04.2026

Actions

Title / Product Name

AUF CD47 GERICHTETE THERAPIEN ZUR BEHANDLUNG VON INFEKTIONSKRANKHEITEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2022185801

EP Publication Number

4119153

E-Number

1678879

Language

PCT Number

Publication Date

18.01.2023 A

24.04.2024 B1

Registration Date

24.04.2024

AT Publication Date

15.05.2024

Application Date

05.02.2014

Registration Number

Priorities

05.02.2013

201361761133 P

IPC

A61K 38/17 20060101AFI20221123BHEP

Maximum Duration of Protection

05.02.2034

Owner

The Board of Trustees of the Leland Stanford Junior UniversityOffice of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386 Stanford, CA 94305-2038US

The United States of America, as represented by the Secretary, Department of Health and Human Services6011 Executive Boulevard, Suite 325, MSC 7660 Bethesda, MD 20892-7660US

The Regents of the University of California1111 Franklin Street, 12th Floor Oakland, CA 94607-5200US

Representative

No representatives present

Inventor

WEISKOPF, Kipp Brookline, 02445US

HASENKRUG, Kim J. Victor, 59875US

STODDART, Cheryl A. Pacifica, 94044US

MCCUNE, Joseph M. San Francisco, 94117US

WEISSMAN, Irving L. Stanford, 94305US